Home Home Home Inbox Home Search

Event

Influence of Key Clinical Baseline Factors on Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma [Board No. 424]

Location: Board no. 424
Session Type: RAPiD: Rapid Abstract Poster Discussion Session
Sunday
May
20
2:15 PM
4:15 PM

Speaker(s)/Author(s)

Mitchell Goldman

MD, PhD
AstraZeneca

James G. Zangrilli

MD
AstraZeneca

Ian Hirsch

PhD
AstraZeneca

Andrew Menzies-Gow

FRCP, PhD
Royal Brompton Hospital

Eugene R. Bleecker

MD
University of Arizona School of Medicine

J. Mark. Fitzgerald

MD
Vancouver General Hospital, UBC Institute for Heart and Lung Health

Yanping Wu

PhD
AstraZeneca

Michael E. Wechsler

MD, MMSc
National Jewish Health

Paul Newbold

PhD
MedImmune LLC

View Abstract

Influence of Key Clinical Baseline Factors on Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma

Parent Sessions

  • A101 - MECHANISMS AND CLINICAL FEATURES OF SEVERE ASTHMA...
    05-20-2018 2:15 PM - 4:15 PM
    • Home Home Home Inbox Home Search